Nachrichten zur Moderna Inc. Aktie

Moderna cancer vaccine breakthrough revives hopes for biotech turnaround

Moderna cancer vaccine breakthrough revives hopes for biotech turnaround…

Schlussglocke: Freundlicher Wochenausklang – Krypto- und Rohstoff-Aktien haussieren, Moderna stark

Die wichtigsten US-amerikanischen Indizes haben sich mit grünen Vorzeichen ins Wochenende verabschiedet. In besonders starker Verfassung präsentierten sich Rohstoff-Aktien und…

Moderna Aktie: Intismeran könnte zum Milliardenprodukt werden - doch ist die Euphorie schon zu groß?

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Morgan Stanley:Die Analysten von Morgan Stanley stufen die Aktie von Moderna Inc. (ISIN: US60770K1079,…

Stocks making the biggest moves midday: Moderna, Robinhood, BJs Wholesale, Coinbase & more

These are some of the stocks posting the largest moves midday.…

Moderna Aktie: William Blair vollzieht die Kehrtwende - Krebs-Durchbruch verändert die Story!

Bad Marienberg (www.aktiencheck.de) - Was für eine Woche für Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol: MRNA)! Erst…

Amid the chip bear market, healthcare is breaking out: Chart of the Day

Moderna stole the show this week, but healthcare has been breaking out for months…

Walmart erhöht Jahresprognose - Scharfe Korrektur nach Kursfeuerwerk bei Moderna - JD Sports-Aktie unter Druck

Wien (www.aktiencheck.de) - Schwächere Umsätze und Ergebnisse bei Mayr-Melnhof (-5,3%) treffen auf eine stärkere Selbsthilfe: Fit-for-Future federte den Gegenwind im…

Modernas Comeback Is Finally Taking Shape -- and There May Be More Upside Ahead

Breaking news: Moderna isnt just a "pandemic stock" after all.…

Stocks making the biggest moves midday: Walmart, Deere, CrowdStrike, Moderna & more

These are some of the stocks posting the largest moves midday.…

Moderna Aktie: Kurssturz! Goldman Sachs bleibt erstaunlich gelassen

Bad Marienberg (www.aktiencheck.de) - Die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol: MRNA) erlebt einen dramatischen…

MRK/MRNAs Personalized Cancer Therapy Delivers First Phase III Win

Merck and Modernas personalized melanoma therapy meet key goals in phase III study, improving recurrence-free and distant metastasis-free survival in…

Cancer vaccine breakthrough at Moderna raises hopes for Scancells melanoma programme

A landmark trial success for Moderna and Mercks cancer vaccine has strengthened the case for Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF,…

Moderna oncology platform draws Street value after melanoma trial win

Moderna Inc (NASDAQ:MRNA, XETRA:0QF)s melanoma trial success is prompting Wall Street to assign new platform value to the companys oncology…

Moderna Aktie: Positive Studiendaten sorgen für Kurssprung - doch Citi warnt vor offenen Fragen

New York (www.aktiencheck.de) - Moderna-Aktienanalyse der Citigroup:Der Citi-Analyst Geoff Meacham gehe davon aus, dass die Aktien von Moderna Inc. (ISIN:…

Wall Street Breakfast Podcast: Modernas $44B Booster

…

Moderna: Vom Pandemie-Gewinner zum Krebs-Pionier

Moderna betreibt eine programmierbare mRNA-Plattform, die es ermöglicht, medizinische Baupläne schnell zu entwickeln und flexibel auf verschiedene Krankheiten anzupassen.…

Moderna Aktie (Monatschart): Die Mutter aller Aufwärtsgaps - Chartanalyse

Düsseldorf (www.aktiencheck.de) - Moderna-Chartanalyse von HSBC Trinkaus & Burkhardt:Die Analysten von HSBC Trinkaus & Burkhardt nehmen die Aktie von Moderna…

BofA upgrades Moderna after 177% rally driven by cancer vaccine breakthrough

BofA upgrades Moderna after 177% rally driven by cancer vaccine breakthrough…

Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough

The breakthrough sparked a broad biotech rally, lifting Merck, BioNTech, Arcturus, cancer-treatment developers, gene-editing stocks and biotech ETFs.…

Stock Market Today, Aug. 19: Moderna Skyrockets 177% on Positive Phase 3 Melanoma Data

Today, Aug. 19, 2026, Modernas personalized cancer vaccine met its late-stage goal, with the company and Merck planning an FDA…

Moderna, Merck breakthrough could usher in wave of cancer vaccines

Merck and Modernas success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of…

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.…

Moderna-Aktie explodiert – Aktien-Report-Tipp sprintet los – Chance auf 400%!

Die Aktie von Moderna schießt am Mittwoch den Vogel ab. Zur Stunde gewinnt der AKTIONÄR-Depotwert satte 130 Prozent an Wert…

Moderna, Estee Lauder among market cap stock movers on Wednesday

Moderna, Estee Lauder among market cap stock movers on Wednesday…

Biotechfirma: Moderna-Aktie explodiert durch neuen Hautkrebs-Impfstoff

Mit einem Impfstoff gegen Corona feierte Moderna einen großen Erfolg. Jetzt verschafft eine Studie zur Hautkrebsbekämpfung dem Unternehmen einen gigantischen…

Why is Moderna stock surging today?

Why is Moderna stock surging today?…

Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Heres What That Means for Investors.

The treatment combines an mRNA shot with Mercks Keytruda.…

Stocks making the biggest moves midday: Moderna, Pilgrims Pride, Target, gold miners & more

These are the stocks posting the largest moves midday.…

Moderna short-sellers stare at record one-day loss as shares surge on vaccine data

Investors betting against shares of Moderna faced record one-day losses on Wednesday as the biotech companys stock more than doubled…

Moderna: Erfolgreiche Studiendaten zum personalisierten Krebsimpfstoff lösen Kursanstieg um 100 % aus!

Erfolgreiche Phase-3-Studie INTerpath-001 mit Intismeran Autogene treibt den Kurs um 100 % in die Höhe. Signifikante RFS- und DMFS-Verbesserungen…

Market movers: Moderna, Marvell, Lowes, Grey Matters...

…

Stocks making the biggest moves premarket: Moderna, Lowes, Estee Lauder & more

These are the stocks posting the largest moves premarket.…

Merck, Moderna say melanoma skin cancer vaccine meets goals in large trial

Merck and Moderna said on Wednesday a study of a personalized mRNA vaccine combined with the immunotherapy drug Keytruda reduced…

Moderna shares soar as mRNA cancer vaccine succeeds in late-stage trial

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) and Merck & Co Inc (NYSE:MRK, XETRA:6MK) said Wednesday their personalized mRNA cancer vaccine, intismeran, combined...…

Dow rises as bond yields ease, Canada tariff pause lifts sentiment

10:00am: Moderna surges Wall Street is showing signs of relief on Wednesday, with the Dow Jones and S&P 500 moving…

From COVID to Cancer: Moderna Scores Melanoma Breakthrough

By successfully applying individualized mRNA technology to train the immune system against recurring tumor cells, Moderna and Merck have opened…

Earnings, Cancer Vaccine, Long-Term Liquidity: A Busy Pre-Market

Q2 retail earnings continue, Moderna sees positive Phase 3 results, and the Treasury lowers the longer-term bond rate.…

Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?

Shares of Moderna (MRNA) and Merck (MRK) are soaring Wednesday after the companies reported a potentially historic breakthrough for their…

Moderna (MRNA) Q2 2026 Earnings Call Transcript

Net loss improved 5% on international partnerships and manufacturing gains.…

FDA Approval Of Moderna’s mRNA Flu Vaccine Is Great News. Here’s Why

The FDA’s approval is welcome news, and will hopefully open the door to much faster production of an effective vaccine…

Stocks making the biggest moves premarket: Zillow, Peloton, Sandisk, Moderna & more

These are the stocks posting the largest moves in the premarket.…

Moderna, Inc. 2026 Q2 - Results - Earnings Call Presentation

…

Moderna begins first human trial of Bundibugyo Ebola vaccine

Moderna on Tuesday said it has begun its first human trial of an experimental vaccine to protect against Bundibugyo ebolavirus,…

Stocks making the biggest moves premarket: Replimune, Chevron, Apple, Amazon, Moderna & more

These are the stocks posting the largest moves premarket.…

Moderna (MRNA) Reports Q2 Loss, Tops Revenue Estimates

Moderna (MRNA) delivered earnings and revenue surprises of 0.00% and +14.49%, respectively, for the quarter ended June 2026. Do the…

MRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback

Modernas Q2 revenue tops estimates, but shares fall after its phase III norovirus vaccine study misses early success criteria.…

Moderna: A Stock to Watch or a Risky Bet?

Could Moderna be the next big opportunity in biotech? Join our experts as they dissect the companys strengths and weaknesses,…

Moderna Is Up 109% in 2026. Jim Cramer Just Called It Finally Investable Again. Is the Stock a No-Brainer Buy on Its Recent Pullback?

A fresh era of earnings growth may be on the horizon.…

Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights

In the most recent trading session, Moderna (MRNA) closed at $59.49, indicating a -3.77% shift from the previous trading day.…

Moderna set for uneventful Q2 report ahead of key data readouts, says Jefferies

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) is expected to report second quarter results on July 31, with investors focused on the impact…